Andrew L. Larkin

Statistics

Publications

Citations

311

H-Index

Active since

2002

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

GlaxoSmithKline (United Kingdom)

Queen's University

Andrew L. Larkin is an author at Research Triangle Park Foundation specializing in pharmacology, medicinal chemistry, and synthetic medicinal chemistry.

Publications per year

2002–2019

Publications

Directed<i>ortho</i>Metalation−Boronation and Suzuki−Miyaura Cross Coupling of Pyridine Derivatives: A One-Pot Protocol to Substituted Azabiaryls

Andrew L. Larkin, K.A. Ogilvie, Laine A. Green et al. · The Journal of Organic Chemistry · 2007 · 104 citations

Natural Sciences, Chemistry, Medicinal Chemistry +11

Rapid Route to 3,4-Substituted Indoles via a Directed Ortho Metalation−Retro-Mannich Sequence

Brian A. Chauder, Andrew L. Larkin, Victor Snieckus · Organic Letters · 2002 · 61 citations

Natural Sciences, Chemistry, Medicinal Chemistry +16

Opioid Receptor Modulation of Hedonic Taste Preference and Food Intake: A Single‐Dose Safety, Pharmacokinetic, and Pharmacodynamic Investigation With GSK1521498, a Novel μ‐Opioid Receptor Inverse Agonist

Pradeep J. Nathan, Barry V. O’Neill, Mark Bush et al. · The Journal of Clinical Pharmacology · 2011 · 49 citations

Medicine, Pharmacokinetics, Pharmacology +17

Regulation of Ingestive Behaviors in the Rat by GSK1521498, a Novel μ-Opioid Receptor-Selective Inverse Agonist

Diane M. Ignar, Aaron S. Goetz, Kimberly Nichols Noble et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 43 citations

Medicine, Neuroscience, Pharmacology +17

The discovery of quinoline-3-carboxamides as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors

David N. Deaton, Young Do, Jason A. Holt et al. · Bioorganic & Medicinal Chemistry · 2019 · 24 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +7

1–5 of 7